Use of the BRANT-MERQS scoring table for the quality assessment of type 3 medication review in patients with rheumatoid arthritis and those with type 2 diabetes mellitus

• Hoofdauteurs: Anneleen Robberechts (Auteur), Kaat Stas (Auteur), Margot Puttemans (Auteur), Laura Poppe (Auteur), Stephane Steurbaut (Auteur), Guido R. Y. De Meyer (Auteur), Hans De Loof (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

BackgroundA type 3 medication review (MR3) is a patient-centred medication service primarily provided by pharmacists and is presently employed routinely in several countries. In this process, pharmacists interview patients and collaborate with the treating physician to optimize the patient's ph...